Amorphical

The company is developing novel solutions for number of major diseases. Amorphical has succeeded to synthesize, stabilize and preserve a naturally rare form of calcium used by nature's most sophisticated "calcium-producing machine" - the blue crayfish, and develop uniquely bioactive, nanometric compositions named Amorphous Calcium Carbonate (ACC). Amorphical is a pioneer biotech company established in Israel in 2004. The company developing novel solutions for number of major diseases. Amorphical has succeeded to stabilize and preserve a rare natural form of calcium used by nature's most sophisticated "calcium-producing machine" - the blue crayfish, and to develop a unique component called nano Amorphous Calcium Carbonate (ACC). ACC consists of nanometric primary particles and it has a much higher solubility & bioavailability than crystalline calcium carbonate (CCC) and it's provide 91% of all essential minerals used by the body, The company has successfully manufactures and marketed several dietary supplements based on ACC, which help build, maintain and restore the body's health and strength, prevent and treat inflammations by efficiently and directly targeting the specific organ or system. The Company currently conducting advanced studies in the fields of cancer (clinical trials on humans), hypoparathyroidism (Phase 2 approved by the FDA) and COVID-19 vaccine development. Amorphical has filed 123 patent applications, 55 of which have been approved. Amorphical goal, is to become a world leader in innovative treatments of cancer, inflammations and metabolic diseases. DENSITY Products The first product launched by the company with great success is DENSITY - a revolutionary ACC supplement. It followed by DENSITY SPORT & DENSITY KIDS. Increased solubility and Increased bioavailability The safest anti-inflammatory substance that are available in the market Reducing pain levels Reduction time of recovery from fracture and from orthopaedicsurgeries Increase in quality of life Read More